Sirnaomics has sealed a $105 million Series D financing co-led by Rotating Boulder Fund, Walvax Biotechnology, and Sunshine Riverhead Capital. Read More
BOSTON, MA, Scorpion Therapeutics announced the closing of a $108 million Series A financing, led by Atlas Venture, Omega Funds, and Vida Ventures. Read More